Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Triangle (HCTI) Cash from Operations (2020 - 2025)

Historic Cash from Operations for Healthcare Triangle (HCTI) over the last 6 years, with Q3 2025 value amounting to -$1.5 million.

  • Healthcare Triangle's Cash from Operations fell 30937.06% to -$1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$10.5 million, marking a year-over-year decrease of 329148.94%. This contributed to the annual value of -$1.1 million for FY2024, which is 4974.43% up from last year.
  • Healthcare Triangle's Cash from Operations amounted to -$1.5 million in Q3 2025, which was down 30937.06% from -$2.6 million recorded in Q2 2025.
  • Healthcare Triangle's 5-year Cash from Operations high stood at $715000.0 for Q3 2024, and its period low was -$5.6 million during Q1 2025.
  • Over the past 5 years, Healthcare Triangle's median Cash from Operations value was -$1.1 million (recorded in 2022), while the average stood at -$1.4 million.
  • Per our database at Business Quant, Healthcare Triangle's Cash from Operations skyrocketed by 11757.7% in 2022 and then tumbled by 1101400.0% in 2025.
  • Over the past 5 years, Healthcare Triangle's Cash from Operations (Quarter) stood at -$3.2 million in 2021, then crashed by 54.02% to -$5.0 million in 2022, then soared by 112.03% to $599000.0 in 2023, then crashed by 235.39% to -$811000.0 in 2024, then tumbled by 84.59% to -$1.5 million in 2025.
  • Its Cash from Operations stands at -$1.5 million for Q3 2025, versus -$2.6 million for Q2 2025 and -$5.6 million for Q1 2025.